We have previously shown that the male sex steroid testosterone inhibits slightly, but the female sex steroid 17␤-estradiol (E 2 ) potentiates dramatically, the capsaicin receptor-mediated current in rat dorsal root ganglion (DRG) neurons. Here, we used pharmacological methods and the nociceptive behavioral test to determine whether there is a sex difference in capsaicininduced acute pain in rats in vivo and what mechanism underlies this sex difference. Results revealed that intradermal injection of capsaicin induced a dose-dependent nocifensive response in males and females, with the dose required to produce a comparable level of nociception being approximately 3-to 4-fold higher in males than in females. In addition, females during the proestrus stage exhibited significantly greater capsaicin-induced nocifensive responses compared with the estrus stage. Moreover, the female's enhanced sensitivity to the capsaicin-induced nocifensive response was completely reversed by ovariectomy 6 weeks before capsaicin injection. It is noteworthy that intradermal coinjection of E 2 but not progesterone with capsaicin potentiated the capsaicininduced nocifensive response in ovariectomized rats. Likewise, intradermal E 2 injection dose-dependently potentiated the capsaicin-induced nocifensive response in male rats. Furthermore, potentiation by E 2 of the capsaicin-induced nocifensive response in male rats was not significantly reduced by a selective protein kinase C (PKC) inhibitor or by a selective protein kinase A (PKA) inhibitor, indicating that neither PKC nor PKA was involved in the effect of E 2 . These data demonstrate that E 2 mediates the female's enhanced sensitivity to capsaicin-induced acute pain, consistent with potentiation by E 2 of the capsaicin receptor-mediated current in rat DRG neurons.
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Capsaicin, the pungent component of hot chili peppers, activates a distinct subpopulation of primary sensory neurons, with somata in dorsal root, trigeminal, and nodose ganglia (Szallasi and Blumberg, 1999) . Capsaicin exerts its effects by binding to distinct cell-surface receptors. Electrophysiological studies from dorsal root ganglion (DRG) neurons demonstrate that capsaicin generates an inward current that depolarizes the neuron (Heyman and Rang, 1985) . This inward current results from the opening of a nonselective cationic channel that is largely permeable to Na ϩ , K ϩ , and Ca 2ϩ (Oh et al., 1996) . In addition to capsaicin, the capsaicin receptor, transient receptor potential vanilloid subtype 1 (TRPV1), also responds to noxious heat (Ͼ43°C), extracellular protons (pH Ͻ6) (Tominaga et al., 1998) , and its endogenous ligands such as anandamide (Di Marzo et al., 2001) , N-arachidonoyl-dopamine (Huang et al., 2002) , and products of lipoxygenases (Hwang et al., 2000) . TRPV1 activation has been implicated in pain transmission and inflammation-induced thermal hyperalgesia (Caterina et al., 2000; Davis et al., 2000) . A modulation of TRPV1 present on the peripheral endings of nociceptors could therefore affect the detection and the transmission of pain messages by the somatosensory system and the development of inflammatory heat hyperalgesia. Understanding the mechanisms underlying the modulation by various agents of TRPV1 may offer new therapies for reducing pain.
Steroid hormones are known to exert profound effects on the neuronal excitability. Although the effects of steroids seem to be mediated by genomic steroid response elements, accumulated evidence indicates that many steroids modulate directly excitatory glutamate and inhibitory ␥-aminobutyric acid type A and glycine receptors (Majewska et al., 1986; Wu et al., 1990 Wu et al., , 1991 Park-Chung et al., 1997) . Moreover, recent electrophysiological studies from our laboratory demonstrate that neurosteroids, such as dehydroepiandrosterone and pregnenolone sulfate, inhibit the TRPV1-mediated current in acutely dissociated rat DRG neurons . Prompted by these observations, we have examined a series of steroids to investigate the structural requirements for steroid modulation of TRPV1 activity. We were surprised to find that the male sex steroid testosterone (one of dehydroepiandrosterone metabolites) inhibits slightly, but the female sex steroid 17␤-estradiol (E 2 ) potentiates dramatically, the TRPV1-mediated current in rat DRG neurons . These results, together with recent clinical findings that women experience capsaicininduced pain more intensely than men do (Gazerani et al., 2005) , suggest that the sex difference in pain perception results from differential modulation of TRPV1 by different sex steroids. However, it is unclear whether the sex difference in capsaicin-induced acute pain also occurs in rats.
By use of pharmacological methods and the nociceptive behavioral test, the specific aims of the present study were thus to determine whether there is a sex difference in the capsaicin-induced nocifensive response in rats in vivo and to explore the mechanism underlying this sex difference. In particular, we aimed to evaluate the role of female sex steroids such as E 2 in the sex difference in capsaicin-induced acute pain.
Materials and Methods

Animals.
All experiments were performed by use of adult male and female Sprague-Dawley rats. Experimental groups included in our analysis consisted of 9-week-old rats (males, 250 -345 g; females, 165-250 g; ovariectomized females, 215-270 g) and 12-week-old rats (females, 215-290 g; ovariectomized females, 230 -333 g). Rats were housed at a temperature of 22 Ϯ 1°C with a 12-h light/dark cycle. Food and water were available ad libitum. All experiments were performed during the light cycle. Animals arrived in the laboratory at least 1 h before testing and were used once for behavioral experiments. This study was conducted in accordance with the guidelines set by the Laboratory Animal Center of National Cheng Kung University. All experimental protocols used were approved by the Animal Research Committee of Medical College of National Cheng Kung University.
Estrous Cycle Determination. Estrous stages were determined by daily vaginal smear taken beginning 2 weeks before the nociceptive behavioral test through the end of the experiment. Approximately 0.10 ml of 0.9% NaCl was forced into the vaginal canal by use of a Pasteur pipette, and the smear was instantly retrieved and transferred to a clean slide. Each sample was viewed and cytology was categorized by use of the system outlined by Freeman (1994) . In brief, 2 days of the diestrus stage were characterized by a predominance of leukocytes and scattered nucleated and/or cornified epithelial cells, the proestrus stage was characterized by a majority of round, nucleated epithelial cells and an absence of leukocytes, and the estrus stage was characterized by large numbers of cornified squamous epithelial cells.
Bilateral OVX. With use of the general method outlined by Kimura et al. (1987) , the ovaries were resected bilaterally at 6 weeks of age. Each rat was anesthetized with ethyl ether before being placed on its ventral surface without restraint. After an incision made with a small pair of scissors and forceps, the periovarian fat was grasped, and the ovary was pulled through the opening in the musculature. A ligature was placed around each ovary and fallopian tube before the ovaries and periovarian fat were resected bilaterally. Sham operations were also included, in which all of the other procedures were the same, except for the removal of the ovaries. Three or six weeks after ovariectomy (OVX) or sham operation, OVX and sham female rats were subjected to the capsaicin test.
Investigation of the Sex Difference in the Capsaicin-Induced Nocifensive Response in Rats. The experimental procedure used for the capsaicin test was similar to that described previously (Chen et al., 2006) . In brief, 9-week-old male and female rats were placed individually in a 30 ϫ 30 ϫ 30-cm Plexiglas observation box for at least 15 min before drug injection to allow adaptation to the new environment. After the adaptation period, 50 l of vehicle [5% dimethyl sulfoxide (DMSO)] or capsaicin was injected intradermally under the dorsal surface of the rat left hindpaw by use of a microsyringe with a 26-gauge needle. Each rat was then returned to the observation box. The amount of time that animals spent licking and/or lifting the injected paw was measured with a stopwatch and was considered as an indicator of the nocifensive response. The animal was observed individually every 5 min for 15 min, immediately after the injection of vehicle or capsaicin. Five doses (0.12, 0.48, 1.9, 7.6, and 15 g) of capsaicin were used to determine the dose dependence and the sex difference in the capsaicin-induced nocifensive response.
Investigation of the Estrous Cycle Difference in the Capsaicin-Induced Nocifensive Response in Female Rats. To test the possibility that stages of the estrous cycle in female rats may alter the capsaicin-induced nocifensive response, we examined capsaicininduced nocifensive responses in estrus and proestrus female rats whose plasma 17␤-estradiol levels reach basal and peak values, respectively (Freeman, 1994) . Experimentally, separate groups of females (9 weeks of age) were injected intradermally with capsaicin, followed by the 15-min measurement of the animal licking/lifting the injected hindpaw. Five doses (0.12, 0.48, 1.9, 7.6, and 15 g) of capsaicin were used to determine the estrous cycle difference in the capsaicin-induced nocifensive response.
Investigation of the Effect of OVX on the Female's Enhanced Sensitivity to the Capsaicin-Induced Nocifensive Response. To investigate the role of female sex steroids in the female's enhanced sensitivity to the capsaicin-induced nocifensive response, we examined capsaicin-induced paw licking/lifting responses in sham and OVX female rats. Experimentally, 3 or 6 weeks after OVX or sham operation, separate groups of female rats were injected intradermally with 0.48 g of capsaicin, followed by the 15-min measurement of nocifensive responses.
Investigation of What Female Sex Steroid Mediates the Female's Enhanced Sensitivity to the Capsaicin-Induced Nocifensive Response. To determine which of female sex steroids (E 2 or progesterone) is involved in the female's enhanced sensitivity to the capsaicin-induced nocifensive response, we examined capsaicininduced paw licking/lifting responses in OVX rats without steroid replacement, with E 2 replacement, or with progesterone replacement. Experimentally, 6 weeks after OVX, separate groups of OVX females were injected intradermally with capsaicin (0.48 g), capsaicin (0.48 g) ϩ E 2 (1.36 g), or capsaicin (0.48 g) ϩ progesterone (1.57 g), followed by the 15-min measurement of nocifensive responses.
Investigation of Whether Intradermal E 2 Injection Also Potentiates the Capsaicin-Induced Nocifensive Response in Male Rats. To investigate whether E 2 also enhances the capsaicininduced nocifensive response in male rats, we determined the effect of intradermal E 2 injection on the capsaicin-induced paw licking/ lifting response. Experimentally, separate groups of males (9 weeks of age) were injected intradermally with capsaicin (0.48 g) or capsaicin (0.48 g) ϩ E 2 , followed by the 15-min measurement of nocifensive responses. Three doses (0.068, 0.34, and 1.36 g) of E 2 were used to determine whether the effect of E 2 was dose-dependent.
Investigation of the Role of PKC and PKA in Potentiation by E 2 of the Capsaicin-Induced Nocifensive Response in Male Rats. To explore whether protein kinase C (PKC) and protein kinase A (PKA) are involved in E 2 potentiation of capsaicin-induced nociception in male rats, separate groups of males (9 weeks of age) were administered intradermally with 50 l of vehicle (5% DMSO), the selective PKC inhibitor bisindolylmaleimide I (Bis I, 2 g), or the selective PKA inhibitor H89 (10 g) 30 min before injection of 50 l of capsaicin (0.48 g) or capsaicin (0.48 g) ϩ E 2 (1.36 g), followed by the 15-min measurement of paw licking/lifting responses. Doses of Bis I and H89 used here were based on previous studies by Vellani et al. (2006) and Cunha et al. (1999) , respectively. The effectiveness of doses of Bis I (2 g) and H89 (10 g) for inhibiting PKC and PKA, respectively, was further supported by our recent findings that 30-min intraplantar preinjection of the same dose of Bis I or H89 blocked thermal hyperalgesia induced by coinjection of subthreshold doses of capsaicin and E 2 in male rats (unpublished data).
Drugs and Chemicals. The following drugs were used in this study: capsaicin, 17␤-estradiol, progesterone, bisindolylmaleimide I, and H89 dihydrochloride. Capsaicin was obtained from Tocris Cookson Inc. (Bristol, UK), bisindolylmaleimide I and H89 dihydrochloride were obtained from Calbiochem (La Jolla, CA), and other chemicals were obtained from Sigma-Aldrich (St. Louis, MO). Capsaicin, 17␤-estradiol, progesterone, bisindolylmaleimide I, and H89 dihydrochloride were dissolved in DMSO (5%, v/v) in phosphate-buffered saline. phosphate-buffered saline contained 138 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , and 4.3 mM Na 2 HPO 4 , pH 7.4.
Statistical Analysis. Capsaicin dose-response curve was determined by plotting the capsaicin-induced nocifensive response as a function of the capsaicin dose. Data were fitted with the Hill equation:
, where R max is the capsaicin maximal nocifensive response, [capsaicin] is the dose of capsaicin, n H is the Hill coefficient, and ED 50 is the dose by which the half-maximal nocifensive response is induced. Throughout, results were expressed as the mean Ϯ S.E.M. Data were compared statistically by use of one-way analysis of variance (ANOVA) followed by Newman-Keuls post hoc tests or by use of Student's t-tests. Differences were considered significant at p Ͻ 0.05.
Results
Sex Difference in the Capsaicin-Induced Nocifensive
Response Occurs in Rats. Our previous studies reported that intradermal injection of capsaicin into the dorsal surface of the male rat hindpaw produced nociception of rapid onset (5 min), characterized by licking/lifting the injected hindpaw (Chen et al., 2006) . To investigate whether the capsaicininduced nocifensive response in female rats has temporal characteristics similar to those in male rats, we determined the time course of the capsaicin-induced paw licking/lifting behavior in male and female rats. Similar to that elicited in males, the nocifensive response evoked by capsaicin (0.48 g) in females appeared immediately, peaked at 0 to 5 min, and decayed to the baseline at 5 min after capsaicin injection (Fig. 1A) . Injection of vehicle (5% DMSO) produced no nocifensive response in both males and females.
To determine whether there is a sex difference in the capsaicin-induced nocifensive response in rats, we compared paw licking/lifting responses evoked by intradermal injection of capsaicin (0.12-15 g) in male and female rats. During the first 5-min observation period, capsaicin induced the paw licking/lifting response in a dose-dependent fashion, evoking a significant dose effect in males (F 5,41 ϭ 36.14, p Ͻ 0.001, one-way ANOVA) and females (F 5,39 ϭ 32.60, p Ͻ 0.001, one-way ANOVA) (Fig. 1B) . Post hoc tests revealed that capsaicin-injected groups in both sexes displayed a significantly greater nocifensive response (p Ͻ 0.05) at each dose (0.12-15 g) of capsaicin tested compared with the vehicleinjected group. However, compared with male rats, female rats exhibited greater capsaicin-induced nocifensive responses at low and medium doses (0.12-7.6 g) (p Ͻ 0.01 and p Ͻ 0.05, respectively) but not at the maximal dose (15 g) (p Ͼ 0.05). Curve-fit analysis revealed that the capsaicin ED 50 was approximately 3-to 4-fold lower in females than in males (0.56 g in females versus 2.02 g in males). In contrast, both sexes displayed similar capsaicin maximal nocifensive responses (112 s in females versus 110 s in males). Because 0.48 g of capsaicin produced a greater nocifensive response in females than in males (Fig. 1, A and B) , this dose of capsaicin was used for the later experiments (Figs. 3  and 4) .
Estrous Cycle Difference in Capsaicin-Induced Nociception Occurs in Female Rats. To test the possibility that stages of the estrous cycle in female rats may affect the capsaicin-induced nocifensive response, we compared paw licking/lifting responses evoked by intradermal injection of capsaicin (0.12-15 g) in estrus and proestrus female rats whose plasma E 2 concentrations are lowest and highest, respectively (Freeman, 1994) . During the first 5-min observation period, capsaicin induced the paw licking/lifting response in a dose-dependent fashion, evoking a significant Fig. 1 . A, time course of the paw licking/lifting nocifensive response after intradermal injection of capsaicin (CAP) or vehicle into the dorsal surface of the male and female rat left hindpaw. Note that the capsaicin-induced nocifensive response during the first 5-min observation period in females is significantly greater than that observed in males. Each value represents the mean Ϯ S.E.M. of six to eight rats during the 5-min interval as indicated. ‫,ءء‬ p Ͻ 0.01 compared with capsaicin (0.48 g)-injected male rats (one-way ANOVA followed by Newman-Keuls post hoc tests). B, nocifensive responses to various doses of capsaicin in male and female rats. Note that capsaicin dose-dependently induces the nocifensive response in both males and females. Furthermore, capsaicin is more potent rather than efficacious to induce the nocifensive response in females than in males. Each bar represents the amounts of time (seconds) that animals spent licking/lifting the injected paw during the first 5-min observation period (mean Ϯ S.E.M. of 6 -10 rats in each group). ‫,ءء‬ p Ͻ 0.01 and ‫,ء‬ p Ͻ 0.05 compared with capsaicin-injected males at each dose as indicated (one-way ANOVA followed by Newman-Keuls post hoc tests). Each set of data points is fitted with the Hill equation (see Materials and Methods). In females, ED 50 ϭ 0.56 g, R max ϭ 112 s, and n H ϭ 0.745. In males, ED 50 ϭ 2.02 g, R max ϭ 110 s, and n H ϭ 0.797. (Fig. 2) . However, compared with estrus females, proestrus females exhibited greater capsaicin-induced nocifensive responses at low and medium doses (0.12-7.6 g) (p Ͻ 0.05 and p Ͻ 0.01, respectively) but not at the maximal dose (15 g) (p Ͼ 0.05). Curve-fit analysis showed that the capsaicin ED 50 was approximately 1.5-fold higher in estrus females than in proestrus females (0.47 g in estrus females versus 0.31 g in proestrus females). In contrast, both stages of females exhibited similar capsaicin maximal nocifensive responses (140 s in estrus females versus 138 s in proestrus females).
E 2 Mediates the Female's Enhanced Sensitivity to the Capsaicin-Induced Nocifensive Response. To investigate whether female sex steroids play a role in the female's enhanced sensitivity to the capsaicin-induced nocifensive response, we initially examined capsaicin (0.48 g)-induced paw licking/lifting responses in sham female rats and female rats ovariectomized 3 weeks before the capsaicin test. We found that, during the first 5-min observation period, the paw licking/lifting response induced by capsaicin (47 Ϯ 4.9 s, n ϭ 7) in OVX females was not significantly different from that (66 Ϯ 8.4 s, n ϭ 8) observed in sham females (p Ͼ 0.05, unpaired Student's t-test). However, 6 weeks after OVX, the capsaicin-induced paw licking/lifting response in OVX females was significantly less than that seen in age-matched sham females (p Ͻ 0.05, one-way ANOVA followed by Newman-Keuls post hoc tests) (Fig. 3) . To further determine which female sex steroid mediates the female's enhanced sensitivity to the capsaicin-induced nocifensive response, we examined the effect of coinjection of E 2 (1.36 g) or progesterone (1.57 g) with capsaicin (0.48 g) on the capsaicininduced nocifensive response in OVX females. Results revealed that E 2 but not progesterone replacement reversed attenuation of the capsaicin-induced nocifensive response in OVX females. One-way ANOVA followed by Newman-Keuls post hoc tests indicated that the capsaicin-induced paw licking/lifting response in OVX females with E 2 replacement was significantly greater than that observed in OVX females without steroid replacement (p Ͻ 0.05). Moreover, there is no significant difference in capsaicin-induced nocifensive responses between sham females and OVX females with E 2 replacement (p Ͼ 0.05). In contrast, the capsaicin-induced paw licking/lifting response in OVX females with progesterone replacement did not differ significantly from that seen in OVX females without steroid replacement (p Ͼ 0.05).
Intradermal Injection of E 2 Dose-Dependently Potentiates the Capsaicin-Induced Nocifensive Response in Male Rats. To determine whether E 2 also potentiates the capsaicin-induced nocifensive response in male rats, we explored the effect of intradermal injection of E 2 on the capsaicin-induced paw licking/lifting response. As shown in Fig.  4A , E 2 (0.068 -1.36 g) coinjected with capsaicin (0.48 g) dose-dependently potentiated the capsaicin-induced nocifensive response in male rats. One-way ANOVA indicated a main effect of dose (F 3, 28 ϭ 6.455, p Ͻ 0.01). Post hoc tests revealed that the low dose (0.068 g) had no effect on the capsaicin-induced nocifensive response (p Ͼ 0.05). The capsaicin-induced nocifensive response was significantly greater in rats coinjected with medium-dose (0.34 g) and high-dose (1.36 g) E 2 compared with rats injected with capsaicin alone (p Ͻ 0.05 and p Ͻ 0.01, respectively). However, injection of capsaicin (0.48 g) into one hindpaw and E 2 (1.36 g) into the contralateral hindpaw did not potentiate the capsaicin-induced nocifensive response. The mean duration of paw licking/lifting during the first 5-min observation period after drug injection was 39 Ϯ 8.5 s (n ϭ 7), which was not significantly different from that (31 Ϯ 5.4 s, n ϭ 8) seen in animals injected with capsaicin alone (p Ͼ 0.05, one-way ANOVA followed by Newman-Keuls test). E 2 (1.36 g) alone produced no direct nocifensive response. In seven rats, the duration of paw licking/lifting during the first 5-min observation period after E 2 injection was 2 Ϯ 0.4 s, which was not significantly different from that (1 Ϯ 0.6 s, n ϭ 6) seen in rats injected with vehicle (5% DMSO) (p Ͼ 0.05, unpaired Student's t-test). Capsaicin induces a greater nocifensive response in female rats during proestrus than during estrus. Note that capsaicin dose-dependently induces the nocifensive response in both estrus and proestrus females. Furthermore, capsaicin is more potent rather than efficacious to induce the nocifensive response in proestrus females than in estrus females. Each bar represents the amounts of time (seconds) that animals spent licking/lifting the injected paw during the first 5-min observation period (mean Ϯ S.E.M. of 6 -9 rats in each group). ‫,ءء‬ p Ͻ 0.01 and ‫,ء‬ p Ͻ 0.05 compared with estrus females at each capsaicin dose as indicated (one-way ANOVA followed by Newman-Keuls post hoc tests). Each set of data points is fitted with the Hill equation (see Materials and Methods). In estrus females, ED 50 ϭ 0.47 g, R max ϭ 140 s, and n H ϭ 0.788. In proestrus females, ED 50 ϭ 0.31 g, R max ϭ 138 s, and n H ϭ 0.919. Fig. 3 . E 2 but not progesterone replacement reverses attenuation of the capsaicin-induced nocifensive response in female rats OVX 6 weeks before capsaicin injection. Note that the nocifensive response induced by intradermal injection of 0.48 g of capsaicin is less in OVX females than in sham females. In addition, E 2 (1.36 g) replacement (OVX ϩ E 2 ) reverses the decrease in the capsaicin-induced nocifensive response in OVX females. In contrast, progesterone (1.57 g) replacement (OVX ϩ P) has little effect on the capsaicin-induced nocifensive response in OVX females. Each bar represents the amounts of time (seconds) that animals spent licking/lifting the injected paw during the first 5-min observation period (mean Ϯ S.E.M. of 6 -7 rats in each group). ‫,ء‬ p Ͻ 0.05 compared with sham females and #, p Ͻ 0.05 compared with OVX females (one-way ANOVA followed by Newman-Keuls post hoc tests). To investigate whether PKC and PKA are involved in potentiation by E 2 of the capsaicininduced nocifensive response in male rats, separate groups of males were administered intradermally with vehicle (5% DMSO), the selective PKC inhibitor Bis I (2 g), or the selective PKA inhibitor H89 (10 g) 30 min before injection of capsaicin (0.48 g) or capsaicin (0.48 g) plus E 2 (1.36 g), followed by the 15-min measurement of paw licking/lifting responses. One-way ANOVA indicated a main effect of treatment [(Veh, CAP), (Veh, CAP ϩ E 2 ), (Bis I, CAP ϩ E 2 ), and (H89, CAP ϩ E 2 )] (F 3,21 ϭ 5.466, p Ͻ 0.01) (Fig. 4B) . Post hoc tests revealed that coinjection of E 2 with capsaicin potentiated the capsaicin-induced nocifensive response in vehiclepretreated rats (p Ͻ 0.01). In addition, neither Bis I nor H89 pretreatment significantly reduced potentiation by E 2 of the capsaicin-induced nocifensive response (p Ͼ 0.05).
Estradiol Mediates Sex Difference in Capsaicin-
Discussion
Although large numbers of clinical and animal studies have indicated that there are sex and menstrual/estrous cycle differences in pain perception of various pain models (Fillingim et al., 1997; Bradshaw et al., 2000; Craft et al., 2004; Cook and Nickerson, 2005; Gazerani et al., 2005) , it remains unclear whether sex and estrous cycle differences in capsaicin-induced acute pain also occur in rats. In the present study, we demonstrate that capsaicin time-and dose dependently induces the nocifensive response in both male and female rats, with females being more sensitive than males to capsaicin (Fig. 1) . Curve-fit analysis further indicates that capsaicin is more potent rather than efficacious to elicit the nocifensive response in females than in males. To achieve comparable profiles of nociception, males require a dose of capsaicin approximately 3-to 4-fold higher than that in females. Our results are in agreement with the previous report that female rats display significantly greater nociceptive responses than male rats after hindpaw injection of formalin (Gaumond et al., 2002) . In the hot-plate test, there is also a sex difference in the acute thermal nociceptive response (Stoffel et al., 2005) . Consistent with our observation, capsaicin injected into the tail produces a dose-dependent thermal hyperalgesia in both male and female rats, with females being more sensitive to capsaicin than males (Barrett et al., 2003) .
To investigate whether stages of estrous cycle in female rats affect the capsaicin-induced nocifensive response, we compared capsaicin-induced nocifensive responses in estrus and proestrus females, whose peripheral plasma concentrations of 17␤-estradiol are lowest and highest, respectively (Freeman, 1994) . We found that compared with estrus females, proestrus females exhibited greater capsaicin-induced nocifensive responses (Fig. 2) . Curve-fit analysis suggests that capsaicin is more potent rather than efficacious to induce the nocifensive response in proestrus than estrus females. To produce a comparable level of nociception, estrus females require a dose of capsaicin approximately 1.5-fold higher than that in proestrus females. Similar to our results are two recent studies demonstrating that after complete Freund's adjuvant administration, female rats during proestrus exhibit significantly greater thermal or mechanical hyperalgesia compared with females during two other estrous stages (Bradshaw et al., 2000; Cook and Nickerson, 2005) . In contrast to our data, one report shows that female rats tested in diestrus, proestrus, or estrus have significantly longer hot-plate latencies than male rats, but the nociceptive threshold in each stage does not significantly differ from each other (Stoffel et al., 2005) . Thus, depending on pain models, there are some consistency and inconsistency among the present and previous studies in terms of differences in nociceptive thresholds among female rodents in different estrous stages. Conceivably, different pain models represent different mechanisms of nociception, thereby being differentially affected by fluctuated female sex steroids.
Statistical analysis revealed that proestrus females showed significantly greater capsaicin-induced pain than that of females without vaginal smears at almost every dose used (Figs. 1B and 2) . Because the data shown in females (Fig. 1B) reflect the combination of data derived from proestrus, estrus, and diestrus groups, it is expected that Fig. 4 . A, coinjection of E 2 with capsaicin dose-dependently potentiates the capsaicin-induced nocifensive response in male rats. Each bar represents the amount of time (seconds) that rats spent licking/lifting the injected hindpaw during the first 5-min observation period (mean Ϯ S.E.M. of 6 -8 rats in each group). Note that rats injected with capsaicin (0.48 g) into one hindpaw and E 2 (1.36 g) into the contralateral hindpaw (CAP ipsil, E 2 contral) have a nocifensive response similar to that seen in rats injected with capsaicin (0.48 g) alone. ‫,ءء‬ p Ͻ 0.01 and ‫,ء‬ p Ͻ 0.05 compared with capsaicin (0.48 g)-injected rats (CAP) (one-way ANOVA followed by Newman-Keuls post hoc tests). B, E 2 potentiates the capsaicin-induced nocifensive response through a PKC-and PKA-independent mechanism in male rats. Potentiation of the capsaicin (0.48 g)-induced nocifensive response by E 2 (1.36 g) (Veh, CAP ϩ E 2 ) is not affected by the 30-min pretreatment of the selective PKC inhibitor Bis I (2 g) (Bis I, CAP ϩ E 2 ) or the selective PKA inhibitor H89 (10 g) (H89, CAP ϩ E 2 ). Each bar represents the amount of time (seconds) that rats spent licking/lifting the injected paw during the first 5-min observation period (mean Ϯ S.E.M. of 6 -7 rats in each group). ‫,ءء‬ p Ͻ 0.01 compared with capsaicin-injected rats (Veh, CAP) (one-way ANOVA followed by Newman-Keuls post hoc tests).
females without vaginal smears would display greater capsaicin-induced pain than that of estrus females. However, there is no significant difference in capsaicin-induced pain between these two groups at almost every dose used, suggesting that repeated vaginal smears may enhance capsaicin-induced pain. This conclusion is supported by previous studies showing that repeated vaginal smears affect pain thresholds (Komisaruk and Whipple, 1986) .
Enhancement of the capsaicin-induced nocifensive response in female rats is abolished by OVX 6 weeks, but not 3 weeks, before capsaicin injection (Fig. 3) , suggesting that the female's enhanced pain sensitivity to capsaicin is mediated by circulating female sex steroids and is reversible after OVX. However, this reversal is slow, requiring more than 3 weeks of time for modulation of capsaicin-induced nociception. It has been reported that in mature rats the decrease in female sex steroids after OVX occurs gradually (Chakraborty and Gore, 2004) and that estrogen receptors (ERs) in rat DRG neurons are also down-regulated very slowly after OVX (Ito et al., 2004) . In fact, the expression of ER mRNA in rat DRG neurons is markedly increased after short-term (11 days) OVX compared with sham rats during proestrus (Sohrabji et al., 1994) . After long-term (3 months) OVX, ER mRNA levels are significantly reduced in rat brains compared with sham rats (Rose'Meyer et al., 2003) . Although the long-term change of ER expression levels after OVX needs to be studied in DRG neurons, the up-regulation of ER, including TRPV1 after short-term OVX, may explain why 3 weeks after OVX is insufficient to produce a difference between OVX and sham rats in their sensitivity to capsaicin in light of the estrus/proestrus experiments showing a significant difference between estrus and proestrus responses to capsaicin.
Coinjection of E 2 but not progesterone with capsaicin reverses attenuation of the capsaicin-induced pain in OVX females (Fig. 3) , indicating that E 2 , but not progesterone, mediates the female's enhanced pain sensitivity to capsaicin in rats. The observation that capsaicin induces a greater nocifensive response in females during proestrus relative to estrus (Fig. 2) further supports this conclusion. Our results are consistent with recent studies showing that OVX at least 3 weeks before tail injection of capsaicin significantly decreases the enhanced sensitivity in female rats to capsaicininduced thermal hyperalgesia (Barrett et al., 2003) . Likewise, Stoffel et al. (2005) report that the sex difference in acute thermal pain seems to depend on the presence of E 2 . Although we have identified E 2 as a mediator involved in the sex difference in capsaicin-induced pain in rats, we still can not exclude the possibility that male sex steroids are also involved in the male's reduced pain sensitivity to capsaicin. Similar to OVX rats, E 2 coinjected with capsaicin dosedependently potentiates the capsaicin-induced nocifensive response in male rats (Fig. 4A) , arguing strongly that the reduced capsaicin-induced nocifensive response in males indeed relies on the absence or relatively low levels of estrogens. However, injections of capsaicin into one hindpaw and E 2 into the contralateral hindpaw do not significantly potentiate the capsaicin-induced nocifensive response, indicating that E 2 produces its effect locally but not systematically. These results are consistent with our previous electrophysiological data that E 2 rapidly potentiates the TRPV1-mediated current in male rat DRG neurons and suggest that E 2 acts directly or indirectly through TRPV1 to potentiate capsaicin-induced nociception. Recent studies in male quail report a similar effect of E 2 on acute thermal pain (Evrard and Balthazart, 2004 ). An acute inhibition of the endogenous spinal estrogen synthesis rapidly reduces the behavioral response to a thermal painful stimulus, whereas peripheral or central E 2 treatment enhances the thermal nocifensive response.
Several potential mechanisms whereby E 2 could exert its effect on capsaicin-induced nociception include: 1) activation of PKC; 2) activation of PKA; or 3) direct action on TRPV1. First, the rapid action of E 2 on the activity of hypothalamic neurons has been shown to be mediated by a novel G proteincoupled estrogen receptor that activates the phospholipase C-diacylglycerol-PKC cascade (Qiu et al., 2003) . This observation, together with the findings that ATP, bradykinin, and proteases potentiate TRPV1-mediated responses through PKC (Tominaga et al., 2001; Sugiura et al., 2002; Amadesi et al., 2004) , raises the possibility that E 2 may enhance TRPV1-mediated responses via PKC. However, pretreatment of the PKC inhibitor Bis I fails to reduce potentiation by E 2 of capsaicin-induced pain (Fig. 4B ), indicating that E 2 action is not mediated by PKC. Second, E 2 has been demonstrated to potentiate the kainate-induced current via the cAMP-PKA signaling pathway in rat hippocampal CA1 neurons (Gu and Moss, 1996) . Moreover, considerable evidence indicates that proinflammatory prostaglandins, such as prostaglandin E 2 , sensitize capsaicin responses in rat sensory neurons through activation of PKA to phosphorylate TRPV1 (Lopshire and Nicol, 1998) . It is possible that E 2 may act through the cAMP-PKA pathway to potentiate TRPV1-mediated responses. However, pretreatment of the PKA inhibitor H89 fails to attenuate potentiation by E 2 of capsaicin-induced nociception (Fig. 4B) , arguing strongly that PKA is not involved in E 2 action. Finally, our previous electrophysiological findings that E 2 potentiates rapidly, but its stereoisomer 17␣-estradiol and progesterone have no effect on the TRPV1-mediated current in rat DRG neurons unpublished data) indicate the stereospecific effect of E 2 . Although we do not have radioligand binding data to conclusively exclude the nonspecific mechanism of E 2 action, this high degree of structural specificity for steroid effects suggests a specific site of E 2 action on TRPV1 or its closely associated protein.
In conclusion, we demonstrate, for the first time, that female rats have greater capsaicin-induced nocifensive responses compared with male rats. Furthermore, E 2 , but not progesterone, plays a crucial role in the sex difference in capsaicin-induced nociception in rats. These findings are consistent with our previous electrophysiological data that E 2 , not progesterone, potentiates the TRPV1-mediated current in rat DRG neurons. The mechanism underlying the effect of E 2 on the TRPV1-mediated nocifensive response needs further investigation. A better understanding of how E 2 potentiates capsaicin-induced nociception may offer a new therapeutic strategy for pain management.
